HSBC Holdings’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-25,535
| Closed | -$64.3K | – | 2688 |
|
|
2025
Q1 | $64.3K | Sell |
25,535
-14,488
| -36% | -$36.5K | ﹤0.01% | 2421 |
|
|
2024
Q4 | $75.6K | Hold |
40,023
| – | – | ﹤0.01% | 2504 |
|
|
2024
Q3 | $41.2K | Sell |
40,023
-7,601
| -16% | -$7.83K | ﹤0.01% | 2511 |
|
|
2024
Q2 | $58.1K | Buy |
47,624
+944
| +2% | +$1.15K | ﹤0.01% | 2432 |
|
|
2024
Q1 | $58.8K | Buy |
46,680
+6,614
| +17% | +$8.33K | ﹤0.01% | 2500 |
|
|
2023
Q4 | $70.9K | Hold |
40,066
| – | – | ﹤0.01% | 2153 |
|
|
2023
Q3 | $64.5K | Buy |
+40,066
| New | +$64.5K | ﹤0.01% | 2097 |
|
|
2016
Q2 | – | Sell |
-1,500
| Closed | -$13K | – | 1674 |
|
|
2016
Q1 | $13K | Buy |
+1,500
| New | +$13K | ﹤0.01% | 1693 |
|
|
2014
Q2 | – | Sell |
-2,822
| Closed | -$129K | – | 1495 |
|
|
2014
Q1 | $129K | Buy |
+2,822
| New | +$129K | ﹤0.01% | 1429 |
|